Peginterferon- -2a (40kD) and Ribavirin in Patients with Chronic Hepatitis C: A Phase II Open-Label Study

Author： Sulkowski M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.16, Iss.2, 2002-02, pp. : 105-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Peginterferon-α-2a (40 kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection†

By Keam Susan J.   Cvetković Risto S.  

BioDrugs, Vol. 23, Iss. 1, 2009-01 ,pp. : 63-68

Adis International

Access to resources Recommend Favorite

Spotlight on Peginterferon- -2a (40KD) in Chronic Hepatitis C

By Perry C.M.   Jarvis B.  

BioDrugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 213-217

Adis International

Access to resources Recommend Favorite

Interleukin-2 Plus Ribavirin Versus Interferon- -2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon- -2b Treatment

By Mariano Malaguarnera  

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 407-413

Adis International

Access to resources Recommend Favorite

Good Safety Profile and Efficacy of Leucocyte Interferon- in Combination with Oral Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C: A Multicentre, Randomised, Controlled Study

By Barbaro G.  

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 433-439

Adis International

Access to resources Recommend Favorite

Interferon- Alone versus Interferon- plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon- Treatment

By Tripi S.  

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 299-304

Adis International

Access to resources Recommend Favorite